It's that time again ... so, lets take a look at five pieces of content worth digging into deeper this evening.
BAE Systems ups dividend 9% and lifts profit guidance, despite smaller order book
Despite a slightly reduced order backlog, BAE Systems PLC (LSE:BA.) raised its full‑year dividend by 9% and upgraded profit guidance after a robust H1 performance, underscoring resilience in defence spending. Read more ...
Taylor Wimpey shares drop 6% as cladding costs drive first‑half loss
Taylor Wimpey PLC (LSE:TW.) swung to a £92.1 million pre‑tax loss in H1 2025, primarily due to a £222 million increase in its cladding‑safety provision, and cut its interim dividend. The shares slumped ~6% on the news. Read more ...
Arkle Resources jumps on premium‑priced placing
AIM‑listed miner Arkle Resources PLC (AIM:ARK) saw its stock surge ~35% after announcing a £500,000 placing at a 28% premium to the prior close. The funds will accelerate zinc and lithium exploration in Ireland and Botswana. Read more ...
Cornish Metals says govt investment is “powerful vote of confidence”
Cornish Metals Inc (AIM:CUSN, TSX-V:CUSN, OTC:SBWFF) welcomed the UK National Wealth Fund’s £28.6 million backing for its South Crofty tin project, with CEO Don Turvey calling it “a powerful vote of confidence” in both the company and Cornwall’s wider mining revival. He highlighted tin’s critical role in the clean‑energy transition and the jobs this investment will create locally. Read more ...
AstraZeneca gets clean bill of health
AstraZeneca PLC (LSE:AZN) shares have caught the attention of UBS, which reiterated its 'buy' rating and raised its price target to 14,200p, implying over 27% upside from the current level, after a solid set of second-quarter results.
The drugmaker beat the Swiss Bank's estimates on both sales and operating profit, helped by stronger-than-expected growth in US oncology and a rebound in its rare disease division. Read more ...